HAE Generic Drug Journey

Understanding the Generic Journey

Fresenius Kabi, in partnership with the US Hereditary Angioedema Association, hosted a webinar for healthcare providers, patients, and caregivers who are considering switching to a generic drug therapy to treat acute attacks of hereditary angioedema (HAE).

Presenters are Loretta Dorn, a nurse clinical liaison from Fresenius Kabi, and Dr. Timothy Craig, a clinical researcher and Penn State College of Medicine Distinguished Educator.

Time: 34 Minutes